The impact of soluble tumor necrosis factor receptor etanercept on the treatment of idiopathic pneumonia syndrome after allogeneic hematopoietic stem cell transplantation.
about
B-cell depletion and remissions of malignancy along with cytokine-associated toxicity in a clinical trial of anti-CD19 chimeric-antigen-receptor-transduced T cellsIdiopathic pneumonia syndrome with thrombotic microangiopathy-related changes after allogeneic hematopoietic stem cell transplantation.Concurrent treatment with a tumor necrosis factor-alpha inhibitor and veno-venous extracorporeal membrane oxygenation in a post-hematopoietic stem cell transplant patient with idiopathic pneumonia syndrome: a case reportLung parenchyma-derived IL-6 promotes IL-17A-dependent acute lung injury after allogeneic stem cell transplantationChildren's Oncology Group's 2013 blueprint for research: stem cell transplantation.Cellular inflammatory infiltrate in pneumonitis induced by a single moderate dose of thoracic x radiation in rats.Randomized, double-blind, placebo-controlled trial of soluble tumor necrosis factor receptor: enbrel (etanercept) for the treatment of idiopathic pneumonia syndrome after allogeneic stem cell transplantation: blood and marrow transplant clinical triEmergent Complications in the Pediatric Hematopoietic Stem Cell Transplant PatientReducing the risk for transplantation-related mortality after allogeneic hematopoietic cell transplantation: how much progress has been made?TNF-receptor inhibitor therapy for the treatment of children with idiopathic pneumonia syndrome. A joint Pediatric Blood and Marrow Transplant Consortium and Children's Oncology Group Study (ASCT0521).Various forms of tissue damage and danger signals following hematopoietic stem-cell transplantation.Translational research efforts in biomarkers and biology of early transplant-related complications.An official American Thoracic Society research statement: noninfectious lung injury after hematopoietic stem cell transplantation: idiopathic pneumonia syndrome.Soluble tumor necrosis factor receptor: enbrel (etanercept) for subacute pulmonary dysfunction following allogeneic stem cell transplantation.Idiopathic pneumonia syndrome after hematopoietic cell transplantation: evidence of occult infectious etiologiesHuman biomarker discovery and predictive models for disease progression for idiopathic pneumonia syndrome following allogeneic stem cell transplantation.A biomarker panel for acute graft-versus-host diseaseIn vitro-differentiated TH17 cells mediate lethal acute graft-versus-host disease with severe cutaneous and pulmonary pathologic manifestationsA Critical Care and Transplantation-Based Approach to Acute Respiratory Failure after Hematopoietic Stem Cell Transplantation in Children.Diagnosis and treatment of pulmonary chronic GVHD: report from the consensus conference on clinical practice in chronic GVHD.Diagnostic bronchoscopy in solid-organ and hematopoietic stem cell transplantation.Intestinal barrier loss as a critical pathogenic link between inflammatory bowel disease and graft-versus-host disease.Targeting the Canonical Nuclear Factor-κB Pathway with a High-Potency IKK2 Inhibitor Improves Outcomes in a Mouse Model of Idiopathic Pneumonia Syndrome.Vigorous inflammatory responses in noninfectious pulmonary complication induced by donor lymphocyte infusion.Treatment of acute fibrinous organizing pneumonia following hematopoietic cell transplantation with etanerceptInhibition of acute lethal pulmonary inflammation by the IDO-AhR pathway.High-dose corticosteroids with or without etanercept for the treatment of idiopathic pneumonia syndrome after allo-SCT.Risk factor analysis of idiopathic pneumonia syndrome after allogeneic hematopoietic SCT in children.TNFα from classically activated macrophages accentuates epithelial to mesenchymal transition in obliterative bronchiolitis.Diagnostic and Prognostic Plasma Biomarkers for Idiopathic Pneumonia Syndrome after Hematopoietic Cell Transplantation.Transbronchial biopsy in the management of pulmonary complications of hematopoietic stem cell transplantation.Incidence, clinical features, and risk factors of idiopathic pneumonia syndrome following hematopoietic stem cell transplantation in children.Current Approach to Non-Infectious Pulmonary Complications of Hematopoietic Stem Cell Transplantation.
P2860
Q29620717-1CA71802-52AA-4812-AF40-1DD2A83FFD4EQ33409874-565EEE12-1341-43A2-B3C9-8B4A205647CBQ33420620-96CF2B18-F597-4386-9A25-DDAE52BF39B8Q33758318-E1F01C0F-8D27-4719-B76C-E62B78C3E222Q33783145-3E721149-3205-49EA-B495-5DD0C33371AEQ33996783-1EB35B0B-D13E-41AF-B74D-CCF5B71FC935Q34027424-EB6F20A5-C023-4ABF-94A3-B13E7DB6EEAEQ34522746-B58D37C8-76D1-4FA3-A9DB-CF81CB07100AQ34743469-E3305AC2-1BE3-42E8-B482-59AAAE970FB1Q34858453-577087B4-0E71-4056-92F7-3A972E644A21Q35022269-00DC531E-F5A9-485B-9025-9B88FB6976B6Q35185329-96BD6CE8-C102-4C10-AA3F-D65F1D3C555AQ35694784-B1E04105-928E-4039-9B9A-F3F802AC4FA3Q35714438-349FEBC7-6A12-4F7F-97AF-F9C7C2F50672Q35724040-B4624065-C9D2-405B-B8CF-7EDDBB23BBC4Q36209078-6503B7D1-805E-4CF1-949E-F89186E8F44CQ37041904-98A6BB1C-043B-48F5-A0B6-AA09D03AB8BAQ37086953-37E3734E-D638-4DC8-A5A5-F8D1CA5D5511Q37276584-8247A9C1-7253-4AC0-B8C3-DA2B29A9C123Q37858415-21F0C686-3ABE-4FEA-A587-38F1377DC62DQ38091055-709462E2-8213-4CC8-A753-E467F3277EEAQ38460376-A8E292AC-D190-4290-A867-45999FC60909Q38978799-2FA7BEDD-EC2D-4AF8-87BE-51691C3891E1Q40135885-30369662-D71E-4443-84CF-D64615F28F83Q40963868-2E34D21A-E02A-474C-BCB8-0032B4254B8CQ41147895-6DFF697B-B188-4F76-92FE-28EC1A21982DQ44828700-D6604C9D-6B2E-4DF1-9442-41C8116CD6AFQ45799176-0B687003-290F-4DB3-B103-74894C03BBA7Q46561167-D40930D6-42F6-4C6C-9C7E-76A9520E24F1Q47312420-78DC9A52-FF98-4284-ABE1-04B7A15AB5CEQ50067907-FAEC1AD9-5A31-4D16-9CA2-1838A7A6CC05Q51008175-A78D0A3F-67EE-47FD-A8AE-226A27E8B508Q54253594-7F220585-0A4B-4A43-A159-7A6DB887F013
P2860
The impact of soluble tumor necrosis factor receptor etanercept on the treatment of idiopathic pneumonia syndrome after allogeneic hematopoietic stem cell transplantation.
description
2008 nî lūn-bûn
@nan
2008 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
The impact of soluble tumor ne ...... tic stem cell transplantation.
@ast
The impact of soluble tumor ne ...... tic stem cell transplantation.
@en
The impact of soluble tumor ne ...... tic stem cell transplantation.
@nl
type
label
The impact of soluble tumor ne ...... tic stem cell transplantation.
@ast
The impact of soluble tumor ne ...... tic stem cell transplantation.
@en
The impact of soluble tumor ne ...... tic stem cell transplantation.
@nl
prefLabel
The impact of soluble tumor ne ...... tic stem cell transplantation.
@ast
The impact of soluble tumor ne ...... tic stem cell transplantation.
@en
The impact of soluble tumor ne ...... tic stem cell transplantation.
@nl
P2093
P2860
P1433
P1476
The impact of soluble tumor ne ...... tic stem cell transplantation.
@en
P2093
Dawn Jones
Gregory A Yanik
James L M Ferrara
Joel Whitfield
Joseph Custer
Joseph H Antin
Kenneth R Cooke
Thomas Braun
Vincent T Ho
P2860
P304
P356
10.1182/BLOOD-2008-03-143412
P407
P577
2008-07-29T00:00:00Z